2nd Circuit Asked To Decide Whether Investors Pleaded Falsity, Loss Causation

Mealey's (July 11, 2019, 5:48 PM EDT) -- NEW YORK — Parties in a securities class action lawsuit against a drug company and its co-founders recently asked the Second Circuit U.S. Court of Appeals to determine whether a federal district court erred in dismissing a second amended complaint for failure to plead falsity and loss causation (Michael Nguyen, et al. v. NewLink Genetics Corp., et al., No. 19-642, 2nd Cir.)....